Austar Lifesciences Liabilities 2024

Austar Lifesciences Aktienanalyse

What does Austar Lifesciences do?

Austar Lifesciences Ltd is an Indian manufacturer of pharmaceutical products and medical devices. The company was founded in 2003 by Mr. Sudhir Taneja and is headquartered in the city of Mohali in the state of Punjab. Since its inception, the company has continuously evolved and is now a leading brand in the Indian healthcare market. Austar Lifesciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Austar Lifesciences's Liabilities

Austar Lifesciences's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Austar Lifesciences's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Austar Lifesciences's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Austar Lifesciences's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Austar Lifesciences’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Austar Lifesciences stock

What is the level of liabilities of Austar Lifesciences this year?

Austar Lifesciences has a debt balance of 1.39 B CNY this year.

What were the liabilities of Austar Lifesciences compared to the previous year?

The liabilities of Austar Lifesciences have increased by -7.1% dropped compared to the previous year.

What are the consequences of high debt for investors of Austar Lifesciences?

High liabilities can pose a risk for investors of Austar Lifesciences, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Austar Lifesciences?

Low liabilities mean that Austar Lifesciences has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Austar Lifesciences affect the company?

An increase in liabilities of Austar Lifesciences can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Austar Lifesciences affect the company?

A decrease in the liabilities of Austar Lifesciences can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Austar Lifesciences?

Some factors that can influence the liabilities of Austar Lifesciences include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Austar Lifesciences so important for investors?

The liabilities of Austar Lifesciences are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Austar Lifesciences take to modify the liabilities?

To change its liabilities, Austar Lifesciences can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Austar Lifesciences pay?

Over the past 12 months, Austar Lifesciences paid a dividend of 0.05 CNY . This corresponds to a dividend yield of about 7.51 %. For the coming 12 months, Austar Lifesciences is expected to pay a dividend of 0 CNY.

What is the dividend yield of Austar Lifesciences?

The current dividend yield of Austar Lifesciences is 7.51 %.

When does Austar Lifesciences pay dividends?

Austar Lifesciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Austar Lifesciences?

Austar Lifesciences paid dividends every year for the past 0 years.

What is the dividend of Austar Lifesciences?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Austar Lifesciences located?

Austar Lifesciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Austar Lifesciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Austar Lifesciences from 6/26/2015 amounting to 0.05 CNY, you needed to have the stock in your portfolio before the ex-date on 5/19/2015.

When did Austar Lifesciences pay the last dividend?

The last dividend was paid out on 6/26/2015.

What was the dividend of Austar Lifesciences in the year 2023?

In the year 2023, Austar Lifesciences distributed 0 CNY as dividends.

In which currency does Austar Lifesciences pay out the dividend?

The dividends of Austar Lifesciences are distributed in CNY.